xbi 破位下跌的原因是穿普也要学希拉里，打压药价

President-elect Trump's biotech comments sharply lower biotech ETFs

 

President-elect Trump's biotech comments sharply lower biotech ETFs President-elect Trump's biotech comments sharply lower biotech ETFs SPDR S&P Biotech ETF XBI XBI, -3.62% slumped 1.9% and iShares NASDAQ Biotech ETF IBB IBB, -3.10% sunk 1.8% in pre-market trade on Wednesday after President-elect Donald Trump's Time cover story quoted the celebrity businessman saying "I'm going to bring down drug prices. I don't like what has happened with drug prices." Biotech has experienced an unprecedented rally over the last month on investors' relief at former Democratic presidential candidate Hillary Clinton's loss. Clinton had repeatedly called for regulation of the pharmaceutical industry. XBI rose 12.3% over the last month, and IBB rose 5%, compared with a 3.8% rise in the S&P 500 SPX, +0.06% "Everybody" was cautious about biotech investments before the election, Andrew McDonald, co-portfolio manager of biotech ETFs BBC BBC, -3.98% and BBP BBP, -3.61% told MarketWatch in mid-November. But now, "it's just getting started. Most people aren't sure this is real...but we've just taken 90% of the risks in the sector away."

如果你目前没有xbi，ibb仓位，还是观望为好。开盘后ibb，xbi已经回踩了各自的关键支持点，有小反弹，看目前形势有要再次去试一次那个支持点的迹象。YMYD